Evidence map›Paper›PMID 31138809›Full record

ArticleNPJ primary care respiratory medicine2019

An accurate prediction model to identify undiagnosed at-risk patients with COPD: a cross-sectional case-finding study.

Kang-Cheng Su, Hsin-Kuo Ko, Kun-Ta Chou, Yi-Han Hsiao, Vincent Yi-Fong Su, Diahn-Warng Perng, Yu Ru Kou

Abstract read
In one paragraph

Article in NPJ primary care respiratory medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. A Two-Staged, Risk-Stratified Strategy Combining FEVRespirology (Carlton, Vic.) · 2025
    Observational
  3. Article
  4. Current Progress of COPD Early Detection: Key Points and Novel Strategies.International journal of chronic obstructive pulmonary disease · 2023
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Kang-Cheng SuInstitute of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
Hsin-Kuo KoDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.
Kun-Ta ChouDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.ORCID http://orcid.org/0000-0002-4822-5474
Yi-Han HsiaoInstitute of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.
Vincent Yi-Fong SuDepartment of Internal Medicine, Taipei City Hospital Yangming Branch, Taipei, Taiwan, ROC.
Diahn-Warng PerngDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC. dwperng@vghtpe.gov.tw.
Yu Ru KouInstitute of Physiology, School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC. yrkou@ym.edu.tw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Underuse or unavailability of spirometry is one of the most important factors causing underdiagnosis of COPD. We reported the development of a COPD prediction model to identify at-risk, undiagnosed COPD patients when spirometry was unavailable. This cross-sectional study enrolled subjects aged ≥40 years with respiratory symptoms and a smoking history (≥20 pack-years) in a medical center in two separate periods (development and validation cohorts). All subjects completed COPD assessment test (CAT), peak expiratory flow rate (PEFR) measurement, and confirmatory spirometry. A binary logistic model with calibration (Hosmer-Lemeshow test) and discrimination (area under receiver operating characteristic curve [AUROC]) was implemented. Three hundred and one subjects (development cohort) completed the study, including non-COPD (154, 51.2%) and COPD cases (147; stage I, 27.2%; II, 55.8%; III-IV, 17%). Compared with non-COPD and GOLD I cases, GOLD II-IV patients exhibited significantly higher CAT scores and lower lung function, and were considered clinically significant for COPD. Four independent variables (age, smoking pack-years, CAT score, and percent predicted PEFR) were incorporated developing the prediction model, which estimated the COPD probability (P

Indexed as

Mass ScreeningAgedCross-Sectional StudiesFemaleForced Expiratory VolumeHumansMalePrimary Health CarePulmonary Disease, Chronic ObstructiveRisk FactorsROC CurveSpirometrySurveys and Questionnaires

Identifiers

PMID31138809
PMCPMC6538645

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.